Gossamer Bio, Inc.GOSSNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | -88.01% | +40.23% | +47.13% |
| Gross Profit Growth | +0.00% | +0.00% | -88.01% | +40.23% | +44.71% |
| EBITDA Growth | +0.00% | +0.00% | -161.34% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | -174.42% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | -177.74% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | -177.27% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | -180.95% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +0.53% | +0.48% | +0.47% | +0.72% | +0.00% |
| Weighted Average Shares Diluted Growth | +0.53% | +0.48% | -4.72% | +0.72% | +0.00% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | -140.45% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | -140.49% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +119.87% | +46.37% | +134.68% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +1.08% | +8.19% | -35.49% | -40.49% | -45.37% |
| Book Value per Share Growth | -53.26% | +0.00% | +0.00% | +0.00% | +0.00% |
| Debt Growth | -4.51% | -3.00% | +1.99% | -0.37% | -0.45% |
| R&D Expense Growth | +20.49% | +17.44% | +18.49% | +51.93% | +35.49% |
| SG&A Expenses Growth | +3.73% | -9.50% | +0.12% | +10.44% | +13.71% |